Billiontoone Inc (BLLN) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Billiontoone Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLLN Gross Profit Margin (Sep 30 2026)
Q3 		(Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3
Y / Y Revenue Change 47.43 %
Seq. Revenue Change 12.36 %
Revenue In Millions $122.98
Gross Profit Margin 70.86 %
Gross Profit Margin Total Ranking # 903
Gross Profit In Millions $87.15
Y / Y Gross Profit Change 49.18 %
Seq. Gross Profit Change 13.02 %


Commenting Third Quarter 2026 Gross Profit Margin
Billiontoone Inc Gross Profit grew by 13.02 % in Q3 sequentially to 87 millions, while Revenue increased by 12.36 %, this led to improvement in the company's Gross Profit Margin to 70.86 %, above the Billiontoone Inc average Gross Profit Margin.


Observing third quarter 2026 results within Medical Laboratories industry 8 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 903, from total ranking in the previous quarter at 1030.
Learn about Gross Margin
BLLN's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 158
Overall # 894

Gross Profit Margin Statistics
High Average Low
73.17 % 67.28 % 52.62 %
(Mar 31 2026)   (Sep 30 2024)


BLLN Gross Income Trends • More of BLLN's Profitabilty Ratios • BLLN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BLLN's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BLLN's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BLLN's Competitors
Gross Profit Margin Profit Margin for Billiontoone Inc 's Suppliers
Gross Profit Margin Profit Margin for BLLN's Customers

You may also want to know
BLLN's Annual Growth Rates BLLN's Profitability Ratios BLLN's Asset Turnover Ratio BLLN's Dividend Growth
BLLN's Roe BLLN's Valuation Ratios BLLN's Financial Strength Ratios BLLN's Gross Profit Growth
BLLN's Roa BLLN's Inventory Turnover Ratio BLLN's Growth Rates BLLN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Laboratories Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Veracyte Inc   97.85 %$ 148.489  Millions$ 151.754  Millions
Miragen Therapeutics Inc   94.07 %$ 24.225  Millions$ 25.752  Millions
Incyte Corporation  93.02 %$ 1,448.460  Millions$ 1,557.204  Millions
Omniab Inc   84.52 %$ 3.375  Millions$ 3.993  Millions
Maxcyte inc   83.41 %$ 8.468  Millions$ 10.152  Millions
Castle Biosciences Inc   76.75 %$ 78.972  Millions$ 102.891  Millions
Butterfly Network Inc   73.02 %$ 23.802  Millions$ 32.598  Millions
Billiontoone Inc   70.86 %$ 87.145  Millions$ 122.981  Millions
Guardant Health Inc   65.42 %$ 236.153  Millions$ 360.975  Millions
Nrc Health  59.95 %$ 23.021  Millions$ 38.399  Millions
Exagen Inc   58.84 %$ 10.836  Millions$ 18.417  Millions
Caredx Inc   44.61 %$ 62.174  Millions$ 139.362  Millions
Aclarion Inc   43.86 %$ 0.015  Millions$ 0.034  Millions
Ge Healthcare Technologies Inc   40.34 %$ 2,224.000  Millions$ 5,513.000  Millions
Fulgent Genetics Inc   35.33 %$ 31.947  Millions$ 90.412  Millions
Iqvia Holdings Inc   33.83 %$ 1,498.000  Millions$ 4,428.000  Millions
Quest Diagnostics Inc  33.65 %$ 1,042.000  Millions$ 3,097.000  Millions
Medpace Holdings Inc   31.27 %$ 223.885  Millions$ 716.000  Millions
Labcorp Holdings Inc   29.08 %$ 1,108.100  Millions$ 3,810.000  Millions
Personalis Inc   25.67 %$ 6.570  Millions$ 25.596  Millions
Fortrea Holdings Inc   20.17 %$ 139.500  Millions$ 691.500  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.